Medical Weight Loss for Alamogordo, New Mexico Residents

Alamogordo, New Mexico residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Alamogordo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in New Mexico: patients in Alamogordo see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Alamogordo Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Alamogordo it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across New Mexico tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

If you are searching for medical weight loss in Alamogordo, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Alamogordo sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across New Mexico. We care for patients throughout downtown Alamogordo and the greater Otero County area. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every New Mexico patient.

Whether you live in central Alamogordo or out toward the edges of New Mexico, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. We accept HSA and FSA cards for the $119 physician review, which lets many Alamogordo patients use pre-tax dollars toward their care. From the cities to the high desert of New Mexico, New Hope Weight Loss cares for patients entirely by telehealth from our Costa Mesa, California clinic, with no office visit needed.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Alamogordo patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Alamogordo by telehealth.

How Telehealth Works for Alamogordo

The path from curious to treated is short, and it all runs through your screen. People in Alamogordo start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Alamogordo home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Alamogordo

Can I start with New Hope Weight Loss if I am located in Alamogordo?

Yes, you can start from Alamogordo right away. Our physical clinic is in Costa Mesa, California, and we deliver care to Alamogordo, New Mexico by telehealth. A video consultation with Dr. Anjmun Sharma reviews your medical history and confirms your fit for compounded semaglutide or tirzepatide.

Do appointments require me to leave Alamogordo?

They do not. Every appointment is handled by telehealth, so Alamogordo patients never leave home for the doctor. You connect with Dr. Sharma online, and approved medication is sent to your Alamogordo address in cold-pack packaging that shields it from heat during shipping.

What is the pricing for Alamogordo residents?

You will pay $119 for the physician visit. Semaglutide starts at $166 a month or $499 for the 90-day option, and tirzepatide at $233 a month. The medication carries a separate charge. HSA, FSA, Klarna, and Affirm are all accepted, and there is no distance surcharge for Alamogordo.

What areas of Alamogordo do you serve?

We serve patients from across Alamogordo by telehealth, including downtown Alamogordo and the greater Otero County area.

How does telehealth treatment work for Alamogordo patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Alamogordo address. Follow-ups also happen by video.

Alamogordo Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Alamogordo, New Mexico by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.